Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus
U.S. stock indices slump amid tariff talks while healthcare sees major developments: J&J faces a $1.6B lawsuit, new FDA approvals, and a $2B ...